NEXT STOP - COVID TRIAL DATA!
By the time the stock is uplisted (early or late Fall or maybe later) most of the data will be out - 2 COVID trials, one or more basket of cancers (probably breast cancer), some interim NASH data perhaps, maybe the launch of an Alzheimers partnership with big pharma, maybe even a partnership with big pharma. So just about the time the stock runup will begin to lose steam, the uplisting will hit, Robinhood investors and institutions will rush in to buy, and we'll be in the stratosphere, at least temporarily. So this is shaping up to be a very good year for CYTODYN and we need to all express our gratitude to Dr. P, Dr. Davidson, and all the other medical professionals who helped with clinical trials, hospital programs, emergency use for individual patients, and so on. They are working 24/7 and they also realize that investors are part of the formula to make everything succeed including providing the funds needed to execute and save lives. I personally am truly impressed by Dr. P and his willingness to candidly address even the stickiest of issues. It's not just execution - it's life saving execution. This is not intended to "pump" the stock - that is no longer needed. The COVID data will confirm what all of us believe, and will validate the enthusiasm expressed by Dr. P and so many medical pros. Next stop... COVID TRIAL DATA!
News 
Market Data 
Discover 
